Physician profile
David M Mcafee
NPI 1043433154
$3,712.65
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,873 · 2020: $299 · 2021: $377 · 2022: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,472.56 | 2019 | |
| Collegium Pharmaceutical, INC. | $482.07 | 2019-2022 | |
| Abbott Laboratories | $129.67 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $94.10 | 2019-2022 | |
| Medtronic, INC. | $87.44 | 2021 | |
| Biodelivery Sciences International, INC. | $87.04 | 2019-2021 | |
| Grt US Holding, INC. | $72.39 | 2022 | |
| Boston Scientific Corporation | $65.12 | 2021 | |
| Pfizer INC. | $49.31 | 2019-2020 | |
| Flowonix Medical Incorporated | $42.35 | 2019-2020 | |
| Nevro Corp. | $30.54 | 2021 | |
| Stimwave Technologies Incorporated | $22.95 | 2019 | |
| Pacira Therapeutics, INC. | $20.57 | 2019 | |
| Indivior INC. | $20.02 | 2021 | |
| Fidia Pharma USA INC. | $14.82 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $13.06 | 2019 | |
| Kinex Medical Company LLC | $8.64 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcafee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.